394 withdrawn. 394 Phase 2, 80 Phase 1, 54 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 394 | Withdrawn 394 |
| Phase 1 | 80 | Withdrawn 80 |
| Phase 3 | 54 | Withdrawn 54 |
Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin Vancomycin (POC) - Clostridioides Difficile, Vancomycin Resistance Enterococcus Faecium | Phase 2 / Phase 3 | Withdrawn | University of Maryland, Baltimore | 2027-01-01 | 2026-07-29 | |
| Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections | Phase 1 / Phase 2 | Withdrawn | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2026-12-31 | 2026-08-17 | |
| Pre-emptive Anakinra for Cytokine Event Reduction Anakinra (Kineret®) - B-Acute Lymphoblastic Leukemia, CAR-T Cell Therapy | Phase 1 / Phase 2 | Withdrawn | Kevin McNerney | 2026-10-01 | 2026-08-13 | |
| Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation MET-2, Placebo - Gram-negative Bacteremia, Microbial Colonization | Phase 2 | Withdrawn | University Health Network, Toronto | 2026-07-01 | 2026-03-12 | |
| Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV Metformin, Placebo, Fluoxetine - Depression, Hiv | Phase 2 | Withdrawn | University of Minnesota | 2026-07-01 | 2026-07-10 | |
| Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS Human umbilical cord mesenchymal stem cells + best supportive care, Placebo control + best supportive care - COVID-19, ARDS | Phase 1 / Phase 2 | Withdrawn | Baylx Inc. | 2026-06-01 | 2025-12-29 | |
| Ceftriaxone for Post-Treatment Lyme Disease Ceftriaxone treatment, Placebo - Post-Treatment Lyme Disease Syndrome | Phase 1 / Phase 2 | Withdrawn | Hackensack Meridian Health | 2026-05-14 | 2026-05-18 | |
| CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV PDS0101 - HPV Associated Cancers, HIV (Human Immunodeficiency Virus) | Phase 2 | Withdrawn | University of California, San Diego | 2026-04-30 | 2026-08-19 | |
| Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS) Nogapendekin Alfa-Inbakicept (NAI), Allogeneic invariant Natural Killer T (iNKT) Cells (AgenT-797) - Acute Respiratory Distress Syndrome, Severe Community-Acquired Pneum | Phase 2 | Withdrawn | ImmunityBio, Inc. | 2026-04-15 | 2026-05-08 | |
| L9LS-R21 Interaction Single dose of 1800 mg L9LS SC (12mL), Placebo 12 mL SC, Single dose of 225 mg L9LS SC (1.5mL) - Malaria | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-03-01 | 2026-04-09 | |
| Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome Instilled T3, Placebo Therapy - Covid19, SARS-CoV Infection | Phase 2 | Withdrawn | University of Minnesota | 2026-01-15 | 2026-02-10 | |
| HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma Biological G207 - Neoplasms, High Grade Glioma | Phase 2 | Withdrawn | Pediatric Brain Tumor Consortium | 2025-09-01 | 2026-02-10 | |
| Gentian Violet Treatment for Hidradenitis Suppurativa Gentian Violet - Hidradenitis Suppurativa | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2025-08-01 | 2025-09-04 | |
| A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects TQA3605 tablets Placebo, TQA3605 Tablets, Entecavir dispersible tablets - Chronic Hepatitis B | Phase 2 | Withdrawn | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2025-07-09 | 2025-08-03 | |
| A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL) HY004, Cyclophosphamide, Fludarabine Phosphate - B-cell Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Withdrawn | Juventas Cell Therapy Ltd. | 2025-06-30 | 2025-08-08 | |
| A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid Amantadine, Physical, Occupational, Speech Therapy, Provider Counseling - Long COVID, Post-Acute COVID-19 Syndrome | Phase 2 | Withdrawn | University of Texas Southwestern Medical Center | 2025-06-01 | 2025-08-26 | |
| Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy Interferon Beta-1A, X-Ray Imaging, Echocardiography - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Withdrawn | Fred Hutchinson Cancer Center | 2025-04-01 | 2024-07-12 | |
| Community-based Behavioral Intervention to Increase Vaccination Using MOST Health education on COVID and flu vaccination, Nurse-led shared decision-making, Text messages - COVID 19, Influenza | Phase 2 | Withdrawn | New York University | 2025-04-01 | 2025-04-29 | |
| Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations FloMask - reuseable face mask - Acute Respiratory Infection, Asthma Exacerbations | Phase 2 | Withdrawn | Queen Mary University of London | 2025-03-27 | 2025-05-20 | |
| Lot Consistency Study of COVID-19 and Influenza Combination Vaccine coformulated CIC Vaccine, Fluzone HD trivalent - COVID-19, Influenza | Phase 2 / Phase 3 | Withdrawn | Novavax | 2025-02-01 | 2025-03-11 |
Showing 20 of 394. Sign in to see all of them.
COVID-19 (132) · HIV Infections (36) · Burkitt Lymphoma (31) · Coronavirus Infections (20) · Influenza, Human (20) · Acquired Immunodeficiency Syndrome (19) · Hepatitis C (14) · Lymphoma (14) · Lymphoma, Follicular (14) · Lymphoma, Large B-Cell, Diffuse (14) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (14) · Sepsis (14) · Leukemia, Lymphocytic, Chronic, B-Cell (13) · Lymphoma, Mantle-Cell (12) · Lymphoma, Non-Hodgkin (12)
Virus Diseases (295) · RNA Virus Infections (234) · Respiratory Tract Diseases (180) · Respiratory Tract Infections (173) · Lung Diseases (147) · Coronaviridae Infections (138) · Nidovirales Infections (138) · Pneumonia (133) · Pneumonia, Viral (130) · Coronavirus Infections (119) · Immune System Diseases (95) · Pathological Conditions, Signs and Symptoms (84) · Communicable Diseases (77) · Blood-Borne Infections (73)
Hydroxychloroquine (11) · Cyclophosphamide (10) · Ribavirin (10) · fludarabine phosphate (8) · Ritonavir (7) · Rituximab (7) · Standard of Care (6) · peginterferon alfa-2a (6) · Azithromycin (5) · Mycophenolic Acid (5) · Prednisone (5) · Radiotherapy (5) · STI-2020 (5) · Saline Solution (5) · Sodium Chloride (5)
National Institute of Allergy and Infectious Diseases (NIAID) (25) · Sorrento Therapeutics, Inc. (9) · M.D. Anderson Cancer Center (8) · Pfizer (6) · U.S. Army Medical Research and Development Command (6) · University of California, San Francisco (6) · GlaxoSmithKline (5) · University of Minnesota (5) · Bristol-Myers Squibb (4) · ImmunityBio, Inc. (4) · Masonic Cancer Center, University of Minnesota (4) · University of Colorado, Denver (4) · University of Texas Southwestern Medical Center (4) · Washington University School of Medicine (4) · Yale University (4)
United States (126) · China (12) · Canada (11) · France (10) · United Kingdom (10) · Germany (9) · India (7) · Spain (7) · Netherlands (6) · Australia (5) · Italy (5) · South Africa (5) · Thailand (5) · Brazil (4) · Israel (4)
Mike Royal, MD (9) · Ritankar Das, MSc (3) · Bill Arana (2) · Claudio Brunstein, MD, PhD (2) · David B. Clifford, MD (2) · Fengcai Zhu (2) · Joaquin Espinosa, PhD (2) · Kevin V Grimes, MD (2) · Lorenzo Berra, MD (2) · Philip Grant, MD (2) · Professor P.E. Verweij, MD, PhD (2)
PMID 34473343, PMID 35713300, PMID 10801260, PMID 11007769, PMID 11756340, PMID 11832638, PMID 11960602, PMID 12086935, PMID 12681026, PMID 12815141, PMID 1400291, PMID 14685229, PMID 15838784, PMID 16155076, PMID 16218959, PMID 16308421, PMID 16940989, PMID 16953201, PMID 17026483, PMID 17199724, PMID 17213921, PMID 17560332, PMID 17916599, PMID 17941868, PMID 18235087, PMID 1900072, PMID 19538242, PMID 19641203, PMID 19918015, PMID 20004680, PMID 20380657, PMID 20577053, PMID 21832087, PMID 22412837, PMID 22974412, PMID 23489075, PMID 25496504, PMID 2648723, PMID 26794905, PMID 27439433, PMID 29541394, PMID 30061293, PMID 30377252, PMID 30414960, PMID 31226023, PMID 31743697, PMID 32650818, PMID 32938444, PMID 34074163, PMID 3417661
2017 (3), 2015 (2), 2019 (2), P30CA072720 (2), U01NS032228 (2), 2016 (1), 2023 (1), K12TR005104 (1), K23EY019881 (1), N01AI30025 (1), P01CA065493 (1), P30CA013330 (1), P30CA015083 (1), P30CA015704 (1), P30CA016672 (1)